front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |review |
Measuring Brain Activity in Response
to Drug Use
Position Emission Tomography (PET)
measures emissions from radioactively-labeled chemicals that
have been injected into the bloodstream and uses the data to produce
images of the distribution of the chemicals in the body.
In drug abuse research, PET is being
used for a variety of reasons including: to identify the brain sites
where drugs and naturally occurring neurotransmitters act; to show
how quickly drugs reach and activate receptors; to determine how
long drugs occupy these receptors; and to find out how long they
take to leave the brain. PET is also being used to show brain
changes following chronic drug abuse, during withdrawal from drug
use, and during the experience of
drug craving. In
addition, PET can be used to assess the effects of pharmacological
and behavioral therapies for drug addiction on the brain.
|